Subclassification of TILs is pivotal; for instance, cytotoxic T cells (CD8+ T cells) have been reported to be associated with improved clinical outcomes in patients with breast cancer [14–16], but other studies could not confirm this association [17]. This evidence concerns the gene CD8A and breast carcinoma.